nodes	percent_of_prediction	percent_of_DWPC	metapath
Iodixanol—Atrial fibrillation—Capecitabine—colon cancer	0.00378	0.00378	CcSEcCtD
Iodixanol—Bradycardia—Irinotecan—colon cancer	0.00377	0.00377	CcSEcCtD
Iodixanol—Renal impairment—Capecitabine—colon cancer	0.00377	0.00377	CcSEcCtD
Iodixanol—Urinary tract disorder—Vincristine—colon cancer	0.00376	0.00376	CcSEcCtD
Iodixanol—Urethral disorder—Vincristine—colon cancer	0.00373	0.00373	CcSEcCtD
Iodixanol—Rhinitis—Irinotecan—colon cancer	0.00372	0.00372	CcSEcCtD
Iodixanol—Sinusitis—Fluorouracil—colon cancer	0.00371	0.00371	CcSEcCtD
Iodixanol—Cardiac failure—Capecitabine—colon cancer	0.00367	0.00367	CcSEcCtD
Iodixanol—Diplopia—Capecitabine—colon cancer	0.00359	0.00359	CcSEcCtD
Iodixanol—Visual impairment—Irinotecan—colon cancer	0.00357	0.00357	CcSEcCtD
Iodixanol—Rhinitis—Fluorouracil—colon cancer	0.00356	0.00356	CcSEcCtD
Iodixanol—Depressed level of consciousness—Methotrexate—colon cancer	0.00355	0.00355	CcSEcCtD
Iodixanol—Cardiac disorder—Vincristine—colon cancer	0.00353	0.00353	CcSEcCtD
Iodixanol—Hypoaesthesia—Fluorouracil—colon cancer	0.00353	0.00353	CcSEcCtD
Iodixanol—Migraine—Capecitabine—colon cancer	0.00353	0.00353	CcSEcCtD
Iodixanol—Pharyngitis—Fluorouracil—colon cancer	0.00352	0.00352	CcSEcCtD
Iodixanol—Face oedema—Capecitabine—colon cancer	0.00346	0.00346	CcSEcCtD
Iodixanol—Angiopathy—Vincristine—colon cancer	0.00345	0.00345	CcSEcCtD
Iodixanol—Cardiac disorder—Irinotecan—colon cancer	0.00344	0.00344	CcSEcCtD
Iodixanol—Flushing—Irinotecan—colon cancer	0.00344	0.00344	CcSEcCtD
Iodixanol—Cardiac arrest—Capecitabine—colon cancer	0.00341	0.00341	CcSEcCtD
Iodixanol—Angiopathy—Irinotecan—colon cancer	0.00336	0.00336	CcSEcCtD
Iodixanol—Coma—Methotrexate—colon cancer	0.00336	0.00336	CcSEcCtD
Iodixanol—Blood creatinine increased—Capecitabine—colon cancer	0.00336	0.00336	CcSEcCtD
Iodixanol—Immune system disorder—Irinotecan—colon cancer	0.00335	0.00335	CcSEcCtD
Iodixanol—Mental disorder—Vincristine—colon cancer	0.00333	0.00333	CcSEcCtD
Iodixanol—Chills—Irinotecan—colon cancer	0.00333	0.00333	CcSEcCtD
Iodixanol—Dry skin—Capecitabine—colon cancer	0.00329	0.00329	CcSEcCtD
Iodixanol—Pulmonary oedema—Methotrexate—colon cancer	0.00327	0.00327	CcSEcCtD
Iodixanol—Back pain—Vincristine—colon cancer	0.0032	0.0032	CcSEcCtD
Iodixanol—Back pain—Irinotecan—colon cancer	0.00312	0.00312	CcSEcCtD
Iodixanol—Muscle spasms—Irinotecan—colon cancer	0.0031	0.0031	CcSEcCtD
Iodixanol—Asthma—Capecitabine—colon cancer	0.0031	0.0031	CcSEcCtD
Iodixanol—Erythema—Fluorouracil—colon cancer	0.00309	0.00309	CcSEcCtD
Iodixanol—Thrombophlebitis—Methotrexate—colon cancer	0.00308	0.00308	CcSEcCtD
Iodixanol—Bronchospasm—Capecitabine—colon cancer	0.00305	0.00305	CcSEcCtD
Iodixanol—Agitation—Vincristine—colon cancer	0.00304	0.00304	CcSEcCtD
Iodixanol—Angina pectoris—Capecitabine—colon cancer	0.00302	0.00302	CcSEcCtD
Iodixanol—Sweating increased—Capecitabine—colon cancer	0.00302	0.00302	CcSEcCtD
Iodixanol—Ill-defined disorder—Irinotecan—colon cancer	0.00299	0.00299	CcSEcCtD
Iodixanol—Bronchitis—Capecitabine—colon cancer	0.00298	0.00298	CcSEcCtD
Iodixanol—Vertigo—Vincristine—colon cancer	0.00298	0.00298	CcSEcCtD
Iodixanol—Malaise—Irinotecan—colon cancer	0.00291	0.00291	CcSEcCtD
Iodixanol—Vertigo—Irinotecan—colon cancer	0.0029	0.0029	CcSEcCtD
Iodixanol—Syncope—Irinotecan—colon cancer	0.00289	0.00289	CcSEcCtD
Iodixanol—Renal failure acute—Methotrexate—colon cancer	0.00289	0.00289	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Capecitabine—colon cancer	0.00288	0.00288	CcSEcCtD
Iodixanol—Convulsion—Vincristine—colon cancer	0.00287	0.00287	CcSEcCtD
Iodixanol—Hypertension—Vincristine—colon cancer	0.00286	0.00286	CcSEcCtD
Iodixanol—Loss of consciousness—Irinotecan—colon cancer	0.00284	0.00284	CcSEcCtD
Iodixanol—Cough—Irinotecan—colon cancer	0.00282	0.00282	CcSEcCtD
Iodixanol—Hypertension—Irinotecan—colon cancer	0.00279	0.00279	CcSEcCtD
Iodixanol—Anaphylactoid reaction—Methotrexate—colon cancer	0.00276	0.00276	CcSEcCtD
Iodixanol—Acute coronary syndrome—Capecitabine—colon cancer	0.00272	0.00272	CcSEcCtD
Iodixanol—Discomfort—Irinotecan—colon cancer	0.00271	0.00271	CcSEcCtD
Iodixanol—Myocardial infarction—Capecitabine—colon cancer	0.00271	0.00271	CcSEcCtD
Iodixanol—Anaphylactic shock—Vincristine—colon cancer	0.0027	0.0027	CcSEcCtD
Iodixanol—Oedema—Vincristine—colon cancer	0.0027	0.0027	CcSEcCtD
Iodixanol—Conjunctivitis—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Iodixanol—Urinary tract infection—Capecitabine—colon cancer	0.00269	0.00269	CcSEcCtD
Iodixanol—Convulsion—Fluorouracil—colon cancer	0.00268	0.00268	CcSEcCtD
Iodixanol—Confusional state—Irinotecan—colon cancer	0.00266	0.00266	CcSEcCtD
Iodixanol—Nervous system disorder—Vincristine—colon cancer	0.00265	0.00265	CcSEcCtD
Iodixanol—Haematuria—Capecitabine—colon cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Anaphylactic shock—Irinotecan—colon cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Oedema—Irinotecan—colon cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Chest pain—Fluorouracil—colon cancer	0.00263	0.00263	CcSEcCtD
Iodixanol—Hyperhidrosis—Vincristine—colon cancer	0.00261	0.00261	CcSEcCtD
Iodixanol—Discomfort—Fluorouracil—colon cancer	0.0026	0.0026	CcSEcCtD
Iodixanol—Shock—Irinotecan—colon cancer	0.00259	0.00259	CcSEcCtD
Iodixanol—Nervous system disorder—Irinotecan—colon cancer	0.00258	0.00258	CcSEcCtD
Iodixanol—Hyperhidrosis—Irinotecan—colon cancer	0.00255	0.00255	CcSEcCtD
Iodixanol—Confusional state—Fluorouracil—colon cancer	0.00254	0.00254	CcSEcCtD
Iodixanol—Hypotension—Vincristine—colon cancer	0.00253	0.00253	CcSEcCtD
Iodixanol—Bradycardia—Capecitabine—colon cancer	0.00253	0.00253	CcSEcCtD
Iodixanol—Oedema—Fluorouracil—colon cancer	0.00252	0.00252	CcSEcCtD
Iodixanol—Anaphylactic shock—Fluorouracil—colon cancer	0.00252	0.00252	CcSEcCtD
Iodixanol—Rhinitis—Capecitabine—colon cancer	0.00249	0.00249	CcSEcCtD
Iodixanol—Nervous system disorder—Fluorouracil—colon cancer	0.00247	0.00247	CcSEcCtD
Iodixanol—Hypoaesthesia—Capecitabine—colon cancer	0.00247	0.00247	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Vincristine—colon cancer	0.00246	0.00246	CcSEcCtD
Iodixanol—Pharyngitis—Capecitabine—colon cancer	0.00246	0.00246	CcSEcCtD
Iodixanol—Hypotension—Irinotecan—colon cancer	0.00246	0.00246	CcSEcCtD
Iodixanol—Urinary tract disorder—Capecitabine—colon cancer	0.00245	0.00245	CcSEcCtD
Iodixanol—Insomnia—Vincristine—colon cancer	0.00245	0.00245	CcSEcCtD
Iodixanol—Oedema peripheral—Capecitabine—colon cancer	0.00244	0.00244	CcSEcCtD
Iodixanol—Urethral disorder—Capecitabine—colon cancer	0.00243	0.00243	CcSEcCtD
Iodixanol—Paraesthesia—Vincristine—colon cancer	0.00243	0.00243	CcSEcCtD
Iodixanol—Visual impairment—Capecitabine—colon cancer	0.00239	0.00239	CcSEcCtD
Iodixanol—Insomnia—Irinotecan—colon cancer	0.00238	0.00238	CcSEcCtD
Iodixanol—Paraesthesia—Irinotecan—colon cancer	0.00236	0.00236	CcSEcCtD
Iodixanol—Hypotension—Fluorouracil—colon cancer	0.00236	0.00236	CcSEcCtD
Iodixanol—Dyspnoea—Irinotecan—colon cancer	0.00235	0.00235	CcSEcCtD
Iodixanol—Somnolence—Irinotecan—colon cancer	0.00234	0.00234	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Vincristine—colon cancer	0.00233	0.00233	CcSEcCtD
Iodixanol—Fatigue—Vincristine—colon cancer	0.00233	0.00233	CcSEcCtD
Iodixanol—Eye disorder—Capecitabine—colon cancer	0.00232	0.00232	CcSEcCtD
Iodixanol—Dyspepsia—Irinotecan—colon cancer	0.00232	0.00232	CcSEcCtD
Iodixanol—Tinnitus—Capecitabine—colon cancer	0.00231	0.00231	CcSEcCtD
Iodixanol—Pain—Vincristine—colon cancer	0.00231	0.00231	CcSEcCtD
Iodixanol—Asthma—Methotrexate—colon cancer	0.00231	0.00231	CcSEcCtD
Iodixanol—Flushing—Capecitabine—colon cancer	0.0023	0.0023	CcSEcCtD
Iodixanol—Cardiac disorder—Capecitabine—colon cancer	0.0023	0.0023	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0023	0.0023	CcSEcCtD
Iodixanol—Insomnia—Fluorouracil—colon cancer	0.00228	0.00228	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Irinotecan—colon cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Fatigue—Irinotecan—colon cancer	0.00227	0.00227	CcSEcCtD
Iodixanol—Paraesthesia—Fluorouracil—colon cancer	0.00226	0.00226	CcSEcCtD
Iodixanol—Pain—Irinotecan—colon cancer	0.00225	0.00225	CcSEcCtD
Iodixanol—Angiopathy—Capecitabine—colon cancer	0.00225	0.00225	CcSEcCtD
Iodixanol—Dyspnoea—Fluorouracil—colon cancer	0.00225	0.00225	CcSEcCtD
Iodixanol—Somnolence—Fluorouracil—colon cancer	0.00224	0.00224	CcSEcCtD
Iodixanol—Immune system disorder—Capecitabine—colon cancer	0.00224	0.00224	CcSEcCtD
Iodixanol—Chills—Capecitabine—colon cancer	0.00223	0.00223	CcSEcCtD
Iodixanol—Dyspepsia—Fluorouracil—colon cancer	0.00222	0.00222	CcSEcCtD
Iodixanol—Gastrointestinal pain—Vincristine—colon cancer	0.00221	0.00221	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00218	0.00218	CcSEcCtD
Iodixanol—Mental disorder—Capecitabine—colon cancer	0.00217	0.00217	CcSEcCtD
Iodixanol—Feeling abnormal—Irinotecan—colon cancer	0.00217	0.00217	CcSEcCtD
Iodixanol—Erythema—Capecitabine—colon cancer	0.00216	0.00216	CcSEcCtD
Iodixanol—Pain—Fluorouracil—colon cancer	0.00216	0.00216	CcSEcCtD
Iodixanol—Gastrointestinal pain—Irinotecan—colon cancer	0.00215	0.00215	CcSEcCtD
Iodixanol—Upper respiratory tract infection—Methotrexate—colon cancer	0.00214	0.00214	CcSEcCtD
Iodixanol—Abdominal pain—Vincristine—colon cancer	0.00214	0.00214	CcSEcCtD
Iodixanol—Body temperature increased—Vincristine—colon cancer	0.00214	0.00214	CcSEcCtD
Iodixanol—Dysgeusia—Capecitabine—colon cancer	0.00211	0.00211	CcSEcCtD
Iodixanol—Back pain—Capecitabine—colon cancer	0.00209	0.00209	CcSEcCtD
Iodixanol—Abdominal pain—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Body temperature increased—Irinotecan—colon cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Feeling abnormal—Fluorouracil—colon cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Muscle spasms—Capecitabine—colon cancer	0.00208	0.00208	CcSEcCtD
Iodixanol—Drowsiness—Methotrexate—colon cancer	0.00206	0.00206	CcSEcCtD
Iodixanol—Ill-defined disorder—Capecitabine—colon cancer	0.002	0.002	CcSEcCtD
Iodixanol—Urticaria—Fluorouracil—colon cancer	0.002	0.002	CcSEcCtD
Iodixanol—Conjunctivitis—Methotrexate—colon cancer	0.002	0.002	CcSEcCtD
Iodixanol—Body temperature increased—Fluorouracil—colon cancer	0.00199	0.00199	CcSEcCtD
Iodixanol—Haematuria—Methotrexate—colon cancer	0.00196	0.00196	CcSEcCtD
Iodixanol—Malaise—Capecitabine—colon cancer	0.00195	0.00195	CcSEcCtD
Iodixanol—Vertigo—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Iodixanol—Asthenia—Vincristine—colon cancer	0.00194	0.00194	CcSEcCtD
Iodixanol—Syncope—Capecitabine—colon cancer	0.00194	0.00194	CcSEcCtD
Iodixanol—Loss of consciousness—Capecitabine—colon cancer	0.0019	0.0019	CcSEcCtD
Iodixanol—Asthenia—Irinotecan—colon cancer	0.00189	0.00189	CcSEcCtD
Iodixanol—Cough—Capecitabine—colon cancer	0.00188	0.00188	CcSEcCtD
Iodixanol—Hypertension—Capecitabine—colon cancer	0.00186	0.00186	CcSEcCtD
Iodixanol—Diarrhoea—Vincristine—colon cancer	0.00185	0.00185	CcSEcCtD
Iodixanol—Chest pain—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Iodixanol—Arthralgia—Capecitabine—colon cancer	0.00184	0.00184	CcSEcCtD
Iodixanol—Pharyngitis—Methotrexate—colon cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Anxiety—Capecitabine—colon cancer	0.00183	0.00183	CcSEcCtD
Iodixanol—Urinary tract disorder—Methotrexate—colon cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Discomfort—Capecitabine—colon cancer	0.00182	0.00182	CcSEcCtD
Iodixanol—Urethral disorder—Methotrexate—colon cancer	0.00181	0.00181	CcSEcCtD
Iodixanol—Diarrhoea—Irinotecan—colon cancer	0.0018	0.0018	CcSEcCtD
Iodixanol—Dry mouth—Capecitabine—colon cancer	0.0018	0.0018	CcSEcCtD
Iodixanol—Dizziness—Vincristine—colon cancer	0.00179	0.00179	CcSEcCtD
Iodixanol—Pruritus—Fluorouracil—colon cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Visual impairment—Methotrexate—colon cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Confusional state—Capecitabine—colon cancer	0.00178	0.00178	CcSEcCtD
Iodixanol—Oedema—Capecitabine—colon cancer	0.00176	0.00176	CcSEcCtD
Iodixanol—Dizziness—Irinotecan—colon cancer	0.00174	0.00174	CcSEcCtD
Iodixanol—Shock—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Nervous system disorder—Capecitabine—colon cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Eye disorder—Methotrexate—colon cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Diarrhoea—Fluorouracil—colon cancer	0.00173	0.00173	CcSEcCtD
Iodixanol—Tinnitus—Methotrexate—colon cancer	0.00172	0.00172	CcSEcCtD
Iodixanol—Vomiting—Vincristine—colon cancer	0.00172	0.00172	CcSEcCtD
Iodixanol—Cardiac disorder—Methotrexate—colon cancer	0.00171	0.00171	CcSEcCtD
Iodixanol—Rash—Vincristine—colon cancer	0.0017	0.0017	CcSEcCtD
Iodixanol—Hyperhidrosis—Capecitabine—colon cancer	0.0017	0.0017	CcSEcCtD
Iodixanol—Dermatitis—Vincristine—colon cancer	0.0017	0.0017	CcSEcCtD
Iodixanol—Headache—Vincristine—colon cancer	0.00169	0.00169	CcSEcCtD
Iodixanol—Angiopathy—Methotrexate—colon cancer	0.00168	0.00168	CcSEcCtD
Iodixanol—Vomiting—Irinotecan—colon cancer	0.00167	0.00167	CcSEcCtD
Iodixanol—Immune system disorder—Methotrexate—colon cancer	0.00167	0.00167	CcSEcCtD
Iodixanol—Dizziness—Fluorouracil—colon cancer	0.00167	0.00167	CcSEcCtD
Iodixanol—Rash—Irinotecan—colon cancer	0.00166	0.00166	CcSEcCtD
Iodixanol—Dermatitis—Irinotecan—colon cancer	0.00166	0.00166	CcSEcCtD
Iodixanol—Chills—Methotrexate—colon cancer	0.00166	0.00166	CcSEcCtD
Iodixanol—Headache—Irinotecan—colon cancer	0.00165	0.00165	CcSEcCtD
Iodixanol—Hypotension—Capecitabine—colon cancer	0.00165	0.00165	CcSEcCtD
Iodixanol—Mental disorder—Methotrexate—colon cancer	0.00162	0.00162	CcSEcCtD
Iodixanol—Erythema—Methotrexate—colon cancer	0.00161	0.00161	CcSEcCtD
Iodixanol—Nausea—Vincristine—colon cancer	0.00161	0.00161	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00161	0.00161	CcSEcCtD
Iodixanol—Vomiting—Fluorouracil—colon cancer	0.0016	0.0016	CcSEcCtD
Iodixanol—Insomnia—Capecitabine—colon cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Rash—Fluorouracil—colon cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Dermatitis—Fluorouracil—colon cancer	0.00159	0.00159	CcSEcCtD
Iodixanol—Paraesthesia—Capecitabine—colon cancer	0.00158	0.00158	CcSEcCtD
Iodixanol—Headache—Fluorouracil—colon cancer	0.00158	0.00158	CcSEcCtD
Iodixanol—Dysgeusia—Methotrexate—colon cancer	0.00157	0.00157	CcSEcCtD
Iodixanol—Dyspnoea—Capecitabine—colon cancer	0.00157	0.00157	CcSEcCtD
Iodixanol—Nausea—Irinotecan—colon cancer	0.00156	0.00156	CcSEcCtD
Iodixanol—Back pain—Methotrexate—colon cancer	0.00156	0.00156	CcSEcCtD
Iodixanol—Dyspepsia—Capecitabine—colon cancer	0.00155	0.00155	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Fatigue—Capecitabine—colon cancer	0.00152	0.00152	CcSEcCtD
Iodixanol—Pain—Capecitabine—colon cancer	0.00151	0.00151	CcSEcCtD
Iodixanol—Nausea—Fluorouracil—colon cancer	0.0015	0.0015	CcSEcCtD
Iodixanol—Ill-defined disorder—Methotrexate—colon cancer	0.00149	0.00149	CcSEcCtD
Iodixanol—Feeling abnormal—Capecitabine—colon cancer	0.00145	0.00145	CcSEcCtD
Iodixanol—Malaise—Methotrexate—colon cancer	0.00145	0.00145	CcSEcCtD
Iodixanol—Vertigo—Methotrexate—colon cancer	0.00144	0.00144	CcSEcCtD
Iodixanol—Gastrointestinal pain—Capecitabine—colon cancer	0.00144	0.00144	CcSEcCtD
Iodixanol—Cough—Methotrexate—colon cancer	0.0014	0.0014	CcSEcCtD
Iodixanol—Urticaria—Capecitabine—colon cancer	0.0014	0.0014	CcSEcCtD
Iodixanol—Abdominal pain—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Iodixanol—Body temperature increased—Capecitabine—colon cancer	0.00139	0.00139	CcSEcCtD
Iodixanol—Convulsion—Methotrexate—colon cancer	0.00139	0.00139	CcSEcCtD
Iodixanol—Arthralgia—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Iodixanol—Chest pain—Methotrexate—colon cancer	0.00137	0.00137	CcSEcCtD
Iodixanol—Discomfort—Methotrexate—colon cancer	0.00135	0.00135	CcSEcCtD
Iodixanol—Confusional state—Methotrexate—colon cancer	0.00132	0.00132	CcSEcCtD
Iodixanol—Anaphylactic shock—Methotrexate—colon cancer	0.00131	0.00131	CcSEcCtD
Iodixanol—Nervous system disorder—Methotrexate—colon cancer	0.00129	0.00129	CcSEcCtD
Iodixanol—Hyperhidrosis—Methotrexate—colon cancer	0.00127	0.00127	CcSEcCtD
Iodixanol—Asthenia—Capecitabine—colon cancer	0.00126	0.00126	CcSEcCtD
Iodixanol—Pruritus—Capecitabine—colon cancer	0.00125	0.00125	CcSEcCtD
Iodixanol—Hypotension—Methotrexate—colon cancer	0.00123	0.00123	CcSEcCtD
Iodixanol—Diarrhoea—Capecitabine—colon cancer	0.00121	0.00121	CcSEcCtD
Iodixanol—Musculoskeletal discomfort—Methotrexate—colon cancer	0.0012	0.0012	CcSEcCtD
Iodixanol—Insomnia—Methotrexate—colon cancer	0.00119	0.00119	CcSEcCtD
Iodixanol—Paraesthesia—Methotrexate—colon cancer	0.00118	0.00118	CcSEcCtD
Iodixanol—Dyspnoea—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Iodixanol—Somnolence—Methotrexate—colon cancer	0.00117	0.00117	CcSEcCtD
Iodixanol—Dizziness—Capecitabine—colon cancer	0.00117	0.00117	CcSEcCtD
Iodixanol—Dyspepsia—Methotrexate—colon cancer	0.00115	0.00115	CcSEcCtD
Iodixanol—Gastrointestinal disorder—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Iodixanol—Fatigue—Methotrexate—colon cancer	0.00113	0.00113	CcSEcCtD
Iodixanol—Pain—Methotrexate—colon cancer	0.00112	0.00112	CcSEcCtD
Iodixanol—Vomiting—Capecitabine—colon cancer	0.00112	0.00112	CcSEcCtD
Iodixanol—Rash—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Iodixanol—Dermatitis—Capecitabine—colon cancer	0.00111	0.00111	CcSEcCtD
Iodixanol—Headache—Capecitabine—colon cancer	0.0011	0.0011	CcSEcCtD
Iodixanol—Feeling abnormal—Methotrexate—colon cancer	0.00108	0.00108	CcSEcCtD
Iodixanol—Gastrointestinal pain—Methotrexate—colon cancer	0.00107	0.00107	CcSEcCtD
Iodixanol—Nausea—Capecitabine—colon cancer	0.00105	0.00105	CcSEcCtD
Iodixanol—Urticaria—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Iodixanol—Abdominal pain—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Iodixanol—Body temperature increased—Methotrexate—colon cancer	0.00104	0.00104	CcSEcCtD
Iodixanol—Asthenia—Methotrexate—colon cancer	0.000941	0.000941	CcSEcCtD
Iodixanol—Pruritus—Methotrexate—colon cancer	0.000928	0.000928	CcSEcCtD
Iodixanol—Diarrhoea—Methotrexate—colon cancer	0.000898	0.000898	CcSEcCtD
Iodixanol—Dizziness—Methotrexate—colon cancer	0.000868	0.000868	CcSEcCtD
Iodixanol—Vomiting—Methotrexate—colon cancer	0.000834	0.000834	CcSEcCtD
Iodixanol—Rash—Methotrexate—colon cancer	0.000827	0.000827	CcSEcCtD
Iodixanol—Dermatitis—Methotrexate—colon cancer	0.000826	0.000826	CcSEcCtD
Iodixanol—Headache—Methotrexate—colon cancer	0.000822	0.000822	CcSEcCtD
Iodixanol—Nausea—Methotrexate—colon cancer	0.000779	0.000779	CcSEcCtD
